Genix Pharmaceuticals GENPF Stock
Genix Pharmaceuticals Price Chart
Genix Pharmaceuticals GENPF Financial and Trading Overview
| Genix Pharmaceuticals stock price | 0.01 USD |
| Previous Close | 0.01 USD |
| Open | 0.01 USD |
| Bid | 0.01 USD x 2000000 |
| Ask | 0.04 USD x 2000000 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.01 - 0.04 USD |
| Volume | 69 USD |
| Avg. Volume | 0 USD |
| Market Cap | 863.26K USD |
| Beta (5Y Monthly) | 0.467 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GENPF Valuation Measures
| Enterprise Value | 1.93M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Genix Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.467 |
| 52-Week Change | -64.75% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.02 USD |
GENPF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 61.22M |
| Float | 33.55M |
| Short Ratio | N/A |
| % Held by Insiders | 45.20% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2025 |
| Most Recent Quarter (mrq) | January 31, 2026 |
| Next Fiscal Year End | October 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -158.96% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -279438 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.34K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 1.08M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.023 |
| Book Value Per Share (mrq) | -0.017455945 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -91221 USD |
| Levered Free Cash Flow (ttm) | -166404 USD |
Profile of Genix Pharmaceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1055 West Hastings Street |
| ZIP | V6E 2E9 |
| Phone | 604-609-6198 |
| Website | https://genixpharm.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
Q&A For Genix Pharmaceuticals Stock
What is a current GENPF stock price?
Genix Pharmaceuticals GENPF stock price today per share is 0.01 USD.
How to purchase Genix Pharmaceuticals stock?
You can buy GENPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genix Pharmaceuticals?
The stock symbol or ticker of Genix Pharmaceuticals is GENPF.
Which industry does the Genix Pharmaceuticals company belong to?
The Genix Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does Genix Pharmaceuticals have in circulation?
The max supply of Genix Pharmaceuticals shares is 61.22M.
What is Genix Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Genix Pharmaceuticals PE Ratio is now.
What was Genix Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Genix Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the Genix Pharmaceuticals company belong to?
The Genix Pharmaceuticals sector is Healthcare.